)
)
)
GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. Trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners, GATC Health’s risk prediction product, the Derisq™ AI report, accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. GATC Health’s AI platform is also generative, creating intellectual property, extending pipelines, and optimizing assets. By uniting advanced AI, multiomics, and predictive modeling, GATC Health accelerates breakthroughs and reduces costly late-stage failures to bring safer, more effective therapies to patients worldwide. For more information, visit www.gatchealth.com.
Year Founded
2020
Next catalyst (value inflection) update
n/a
Expected time of next catalyst update
n/a
City
Irvine
Country
United States
Company CEO or top company official
Dr Rahul Gupta, president
Development Phase of Primary Product
Other/Not Applicable
Lead Product in Development
n/a
Number of Unlicensed Products
n/a
Therapeutic Area
Tools/Drug Development Support Tech
Website
http://www.gatchealth.com
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
